AnaptysBio, Inc. ANAB Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s total liabilities & equity?
- AnaptysBio, Inc. (ANAB) reported total liabilities & equity of $329.68M in Q1 2026.
- How has AnaptysBio, Inc.'s total liabilities & equity changed year-over-year?
- AnaptysBio, Inc.'s total liabilities & equity decreased by 21.9% year-over-year, from $422.05M to $329.68M.
- What is the long-term trend for AnaptysBio, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total liabilities & equity has grown at a -2.6% compound annual growth rate (CAGR), from $416.55M to $364.4M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.